Influence of aspirin on SR-BI expression in human carotid plaques

Atherosclerosis

Volumn 206, Issue 1, 2009, Pages 234-238

  Wehinger, Andreas ^a,d   Tancevski, Ivan ^a   Seiler, Ruediger ^b   Frotschnig, Sandra M ^a   Frantz, Stefan ^c   Huber, Julia ^a   Eller, Philipp ^a   Schgoer, Wilfried ^a   Foeger, Bernhard ^a,d   Patsch, Josef R ^a   Ritsch, Andreas ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aspirin; Atherosclerosis; Carotid plaque; Macrophages; NF B; SR BI

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CD38 ANTIGEN; CLOPIDOGREL; COUMARIN DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLACEBO; PROTEIN P50; SCAVENGER RECEPTOR BI;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; ENDARTERECTOMY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LOW DRUG DOSE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD36; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ASPIRIN; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; ENDARTERECTOMY, CAROTID; HUMANS; MACROPHAGES; MICE; MICE, KNOCKOUT; NF-KAPPA B;

EID: 69249235765     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.01.034     Document Type: Article

References (29)

1. Acton S., Rigotti A., Landschulz K.T., et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271 (1996) 518-520
2. Cao G., Garcia C.K., Wyne K.L., et al. Structure and localization of the human gene encoding SR-BI/CLA-1. Evidence for transcriptional control by steroidogenic factor 1. J Biol Chem 272 (1997) 33068-33076
3. Murao K., Terpstra V., Green S.R., et al. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J Biol Chem 272 (1997) 17551-17557
4. Ji Y., Jian B., Wang N., et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 272 (1997) 20982-20985
5. Krieger M. Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J Clin Invest 108 (2001) 793-797
6. Van Eck M., Pennings M., Hoekstra M., Out R., and Van Berkel T.J. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis. Curr Opin Lipidol 16 (2005) 307-315
7. Hirano K., Yamashita S., Nakagawa Y., et al. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. Circ Res 85 (1999) 108-116
8. Chinetti G., Gbaguidi F.G., Griglio S., et al. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 101 (2000) 2411-2417
9. Krieger M., and Kozarsky K. Influence of the HDL receptor SR-BI on atherosclerosis. Curr Opin Lipidol 10 (1999) 491-497
10. Van Eck M., Bos I.S., Hildebrand R.B., Van Rij B.T., and Van Berkel T.J. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. Am J Pathol 165 (2004) 785-794
11. Cronstein B.N., and Weissmann G. Targets for antiinflammatory drugs. Annu Rev Pharmacol Toxicol 35 (1995) 449-462
12. Awtry E.H., and Loscalzo J. Aspirin. Circulation 101 (2000) 1206-1218
13. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308 (1994) 81-106
14. Tancevski I., Wehinger A., Schgoer W., et al. Aspirin regulates expression and function of scavenger receptor-BI in macrophages: studies in primary human macrophages and in mice. FASEB J 20 (2006) 1328-1335
15. Frantz S., Hu K., Bayer B., et al. Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction. FASEB J 20 (2006) 1918-1920
16. Tancevski I., Frank S., Massoner P., et al. Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression of human scavenger receptor class B type I. J Mol Med 83 (2005) 927-932
17. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
18. Ritsch A., Tancevski I., Schgoer W., et al. Molecular characterization of rabbit scavenger receptor class B types I and II: portal to central vein gradient of expression in the liver. J Lipid Res 45 (2004) 214-222
19. Cyrus T., Sung S., Zhao L., et al. Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 106 (2002) 1282-1287
20. Shashkin P., Dragulev B., and Ley K. Macrophage differentiation to foam cells. Curr Pharm Des 11 (2005) 3061-3072
21. Mardones P., Pilon A., Bouly M., et al. Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice. J Biol Chem 278 (2003) 7884-7890
22. Silver D.L. SR-BI and protein-protein interactions in hepatic high density lipoprotein metabolism. Rev Endocr Metab Disord 5 (2004) 327-333
23. Yesilaltay A., Kocher O., Rigotti A., and Krieger M. Regulation of SR-BI-mediated high-density lipoprotein metabolism by the tissue-specific adaptor protein PDZK1. Curr Opin Lipidol 16 (2005) 147-152
24. de Winther M.P., Kanters E., Kraal G., and Hofker M.H. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 25 (2005) 904-914
25. Xanthoulea S., Curfs D.M., Hofker M.H., and de Winther M.P. Nuclear factor kappa B signaling in macrophage function and atherogenesis. Curr Opin Lipidol 16 (2005) 536-542
26. Han J., Parsons M., Zhou X., et al. Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104). Circulation 110 (2004) 3472-3479
27. Llaverias G., Rebollo A., Pou J., et al. Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes. Biochem Pharmacol 71 (2006) 605-614
28. Cipollone F., Mezzetti A., Fazia M.L., et al. Association between 5-lipoxygenase expression and plaque instability in humans. Arterioscler Thromb Vasc Biol 25 (2005) 1665-1670
29. Albrecht C., Soumian S., Amey J.S., et al. ABCA1 expression in carotid atherosclerotic plaques. Stroke 35 (2004) 2801-2806